Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News Feature
  • Published:

Rainbow biotech—South Africa's emerging sector

Nature Biotechnology volume 24, pages 1313–1316 (2006)Cite this article

An Erratum to this article was published on 01 February 2007

For South Africa's sparkling biotech sector not to fizzle, it must win over risk-averse investors, exploit local strengths, focus on simple business models and look to the East. Sabine Louët reports.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. Sabine Louët reporting from Johannesburg and Cape Town,

    Sabine Louët

Authors
  1. Sabine Louët
    View author publications

    You can also search for this author in PubMed Google Scholar

Related links

Related links

Web links

eGoli BIO

BioPad

Cape Biotech

Acorn Technologies

PlantBIO

Bio2Biz

LifeLab

National Bioinformatics Network

Rights and permissions

Reprints and permissions

About this article

Cite this article

Louët, S. Rainbow biotech—South Africa's emerging sector. Nat Biotechnol 24, 1313–1316 (2006). https://doi.org/10.1038/nbt1106-1313

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt1106-1313

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing